Clinical Trial Update: A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and potential efficacy of TEV-53408 for vitiligo, sponsored by Teva Branded Pharmaceutical Products R&D LLC; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• TEV-53408

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Vitiligo | Phase 1 | Status: ACTIVE_NOT_RECRUITING